Early atypical malignant transformation of diffuse low-grade astrocytoma: The importance of genotyping

Neurocirugia (Astur : Engl Ed). 2022 Jan-Feb;33(1):31-34. doi: 10.1016/j.neucie.2020.09.001.

Abstract

Diffuse astrocytoma (WHO grade II) has classically been considered a slow growing tumour, typically affecting young adults, with tendency for late malignant conversion. We describe a case of early atypical malignant transformation of diffuse astrocytoma seventeen months after complete surgical removal, as an intraventricular high-grade glioma (HGG). Retrospective laboratory findings for the presence of IDH 1/2 (isocitrate dehydrogenase) mutations were negative. There is growing evidence that IDH-wildtype (wt) astrocytomas behave more aggressively, therefore identifying IDH-mutation status should be mandatory in order to determine disease prognosis and guide treatment course.

Keywords: Astrocitoma difuso; Diffuse astrocytoma; Genotipificar; Glioma de bajo grado; IDH 1/2 mutation; IDH-wildtype; Lower-grade gliomas; Mutación IDH 1/2; Tumour genotype.

Publication types

  • Case Reports

MeSH terms

  • Astrocytoma* / genetics
  • Astrocytoma* / pathology
  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / pathology
  • Genotype
  • Humans
  • Isocitrate Dehydrogenase / genetics
  • Retrospective Studies
  • Young Adult

Substances

  • Isocitrate Dehydrogenase